Synergistic activity of polymyxin B combined with vancomycin against carbapenem-resistant and polymyxin-resistant Acinetobacter baumannii: first in vitro study
Purpose. The effect of a combination of polymyxin B (PMB) and vancomycin (VAN) was assessed against six Acinetobacter baumannii clinical isolates belonging to six different clusters (three PMB-susceptible and three PMB-resistant).
Methodology. The synergistic effect of the PMB–VAN combination was determined with the checkerboard, time-kill, disk-diffusion and M.I.C.Evaluator assays. PMB-resistance was investigated with mcr-1 gene amplification and a mutant frequency assay.
Results. In the checkerboard assay, all PMB-resistant isolates showed a synergistic effect. The time-kill assay demonstrated that the PMB–VAN combination had a bactericidal effect at 24 h against isolates with a high mutant rate for PMB, suggesting that this combination may block the hypermutation of some isolates. No antagonism was detected. All PMB-resistant isolates also showed synergism in the disk-diffusion test, and a significant decrease in VAN MICs in the M.I.C.Evaluator assay.
Conclusion. Our findings indicate that the PMB–VAN combination has a synergistic effect on A. baumannii, especially against PMB-resistant isolates.
RyngaD, ShariffM, DebM. Phenotypic and molecular characterization of clinical isolates of Acinetobacter baumannii isolated from Delhi, India. Ann Clin Microbiol Antimicrob2015; 14:40 [View Article]
LemosEV, de la HozFP, EinarsonTR, McGhanWF, QuevedoE et al. Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis. Clin Microbiol Infect2014; 20:416–423 [View Article]
GordonNC, PngK, WarehamDW. Potent synergy and sustained bactericidal activity of a vancomycin-colistin combination versus multidrug-resistant strains of Acinetobacter baumannii. Antimicrob Agents Chemother2010; 54:5316–5322 [View Article]
MenegucciTC, AlbieroJ, MiglioriniLB, AlvesJL, VianaGF et al. Strategies for the treatment of polymyxin B-resistant Acinetobacter baumannii infections. Int J Antimicrob Agents2016; 47:380–385 [View Article]
Clinical and Laboratory Standards InstituteMethods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard Document M07-A10 , 10th ed. Wayne, PA: 2015
LiuYY, WangY, WalshTR, YiLX, ZhangR et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis2016; 16:161–168 [View Article]
YangH, LvN, HuL, LiuY, ChengJ et al. In vivo activity of vancomycin combined with colistin against multidrug-resistant strains of Acinetobacter baumannii in a Galleria mellonella model. Infect Dis (Lond)2016; 48:189–194 [View Article]
FowerakerJE, LaughtonCR, BrownDF, BiltonD. Comparison of methods to test antibiotic combinations against heterogeneous populations of multiresistant Pseudomonas aeruginosa from patients with acute infective exacerbations in cystic fibrosis. Antimicrob Agents Chemother2009; 53:4809–4815 [View Article]
PercinD, AkyolS, KalinG. In vitro synergism of combinations of colistin with selected antibiotics against colistin-resistant Acinetobacter baumannii. GMS Hyg Infect Control2014; 9:Doc14 [View Article]
GrabowiczM, AndresD, LebarMD, MalojčićG, KahneD et al. A mutant Escherichia coli that attaches peptidoglycan to lipopolysaccharide and displays cell wall on its surface. Elife2014; 3:e05334 [View Article]
HenryR, VithanageN, HarrisonP, SeemannT, CouttsS et al. Synergistic interactions of vancomycin with different antibiotics against Escherichia coli: trimethoprim and nitrofurantoin display strong synergies with vancomycin against wild-type E. coli. Antimicrob Agents Chemother2012; 56:59–69
Garnacho-MonteroJ, Amaya-VillarR, Gutiérrez-PizarrayaA, Espejo-Gutiérrez de TenaE, Artero-GonzálezML et al. Clinical efficacy and safety of the combination of colistin plus vancomycin for the treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii. Chemotherapy2013; 59:225–231 [View Article]
KalinG, AlpE, CoskunR, DemiraslanH, GündoganK et al. Use of high-dose IV and aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia: do we really need this treatment?. J Infect Chemother2012; 18:872–877 [View Article]
ZavasckiAP, NationRL. Nephrotoxicity of polymyxins: is there any difference between colistimethate and polymyxin B?. Antimicrob Agents Chemother2017; 61:e02319–16 [View Article]
SampsonTR, LiuX, SchroederMR, KraftCS, BurdEM et al. Rapid killing of Acinetobacter baumannii by polymyxins is mediated by a hydroxyl radical death pathway. Antimicrob Agents Chemother2012; 56:5642–5649 [View Article]
ZhouA, KangTM, YuanJ, BepplerC, NguyenC et al. Synergistic interactions of vancomycin with different antibiotics against Escherichia coli: trimethoprim and nitrofurantoin display strong synergies with vancomycin against wild-type E. coli. Antimicrob Agents Chemother2015; 59:276–281 [View Article]
Synergistic activity of polymyxin B combined with vancomycin against carbapenem-resistant and polymyxin-resistant Acinetobacter baumannii: first in vitro study